These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 21676369

  • 1. High-sensitivity troponin T level and angiographic severity of coronary artery disease.
    Ndrepepa G, Braun S, Schulz S, Mehilli J, Schömig A, Kastrati A.
    Am J Cardiol; 2011 Sep 01; 108(5):639-43. PubMed ID: 21676369
    [Abstract] [Full Text] [Related]

  • 2. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C, Prontera C, Liga R, De Graaf MA, Gaemperli O, Lorenzoni V, Ragusa R, Marinelli M, Del Ry S, Rovai D, Giannessi D, Aguade-Bruix S, Clemente A, Bax JJ, Lombardi M, Sicari R, Zamorano J, Scholte AJ, Kaufmann PA, Knuuti J, Underwood SR, Clerico A, Neglia D.
    Arterioscler Thromb Vasc Biol; 2016 Apr 01; 36(4):757-64. PubMed ID: 26868212
    [Abstract] [Full Text] [Related]

  • 3. Epicardial fat thickness in stable coronary artery disease: its relationship with high-sensitive cardiac troponin T and N-terminal pro-brain natriuretic peptide.
    Börekçi A, Gür M, Özaltun B, Baykan AO, Harbalioğlu H, Seker T, Sen Ö, Acele A, Gözükara MY, Kuloğlu O, Koç M, Çayli M.
    Coron Artery Dis; 2014 Dec 01; 25(8):685-90. PubMed ID: 25004239
    [Abstract] [Full Text] [Related]

  • 4. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
    Peer A, Falkensammer G, Alber H, Kroiss A, Griesmacher A, Ulmer H, Pachinger O, Mair J.
    Heart; 2009 Feb 01; 95(4):297-303. PubMed ID: 18708421
    [Abstract] [Full Text] [Related]

  • 5. High-sensitivity cardiac troponin T level is associated with angiographic complexity of coronary artery disease: a cross-sectional study.
    Yamazaki K, Iijima R, Nakamura M, Sugi K.
    Heart Vessels; 2016 Jun 01; 31(6):890-6. PubMed ID: 25964074
    [Abstract] [Full Text] [Related]

  • 6. The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T.
    Laufer EM, Mingels AM, Winkens MH, Joosen IA, Schellings MW, Leiner T, Wildberger JE, Narula J, Van Dieijen-Visser MP, Hofstra L.
    Arterioscler Thromb Vasc Biol; 2010 Jun 01; 30(6):1269-75. PubMed ID: 20299689
    [Abstract] [Full Text] [Related]

  • 7. Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction.
    Ndrepepa G, Braun S, Mehilli J, von Beckerath N, Vogt W, Schömig A, Kastrati A.
    Am J Cardiol; 2005 Mar 01; 95(5):553-7. PubMed ID: 15721090
    [Abstract] [Full Text] [Related]

  • 8. Troponin T and N-terminal pro B-Type natriuretic peptide and presence of coronary artery disease.
    Mouridsen MR, Sajadieh A, Carlsen CM, Mattsson N, Heitmann M, Nielsen OW.
    Scand J Clin Lab Invest; 2015 May 01; 75(3):204-12. PubMed ID: 25629204
    [Abstract] [Full Text] [Related]

  • 9. Links between sleep disordered breathing, coronary atherosclerotic burden, and cardiac biomarkers in patients with stable coronary artery disease.
    Inami T, Seino Y, Otsuka T, Yamamoto M, Kimata N, Murakami D, Takano M, Ohba T, Ibuki C, Mizuno K.
    J Cardiol; 2012 Sep 01; 60(3):180-6. PubMed ID: 22525967
    [Abstract] [Full Text] [Related]

  • 10. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
    Lyngbæk S, Winkel P, Gøtze JP, Kastrup J, Gluud C, Kolmos HJ, Kjøller E, Jensen GB, Hansen JF, Hildebrandt P, Hilden J, CLARICOR Trial Group.
    Eur J Prev Cardiol; 2014 Oct 01; 21(10):1275-84. PubMed ID: 23723326
    [Abstract] [Full Text] [Related]

  • 11. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E, Wuppinger T, Bode T, Alber H, Ulmer H, Pachinger O, Mair J.
    Coron Artery Dis; 2012 Mar 01; 23(2):91-7. PubMed ID: 22157356
    [Abstract] [Full Text] [Related]

  • 12. Correlation of concentrations of high-sensitivity troponin T and high-sensitivity C-reactive protein with plaque progression as measured by CT coronary angiography.
    Seifarth H, Schlett CL, Lehman SJ, Bamberg F, Donnelly P, Januzzi JL, Koenig W, Truong QA, Hoffmann U.
    J Cardiovasc Comput Tomogr; 2014 Mar 01; 8(6):452-8. PubMed ID: 25467832
    [Abstract] [Full Text] [Related]

  • 13. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M, Karaarslan O, Abali G, Batur MK.
    Tex Heart Inst J; 2010 Mar 01; 37(1):42-8. PubMed ID: 20200626
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
    Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Røsjø H, Šaltytė Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald E, PEACE Investigators.
    J Am Coll Cardiol; 2013 Mar 26; 61(12):1240-9. PubMed ID: 23414791
    [Abstract] [Full Text] [Related]

  • 15. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
    Dai DF, Hwang JJ, Lin JL, Lin JW, Hsu CN, Lin CM, Chiang FT, Lai LP, Hsu KL, Tseng CD, Tseng YZ.
    Circ J; 2008 Aug 26; 72(8):1316-23. PubMed ID: 18654020
    [Abstract] [Full Text] [Related]

  • 16. High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study.
    Ivandic BT, Spanuth E, Kleber M, Grammer TB, März W.
    Clin Chem Lab Med; 2011 Jun 26; 49(6):1053-8. PubMed ID: 21574877
    [Abstract] [Full Text] [Related]

  • 17. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Giannitsis E, Spanuth E, Horsch A, Kleber ME, Koch W, Grammer TB, Koenig W, März W.
    Clin Chem Lab Med; 2013 Oct 26; 51(10):2019-28. PubMed ID: 24072576
    [Abstract] [Full Text] [Related]

  • 18. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
    Harutyunyan MJ, Mathiasen AB, Winkel P, Gøtze JP, Hansen JF, Hildebrandt P, Jensen GB, Hilden J, Jespersen CM, Kjøller E, Kolmos HJ, Gluud C, Kastrup J, CLARICOR Trial Group.
    Scand J Clin Lab Invest; 2011 Feb 26; 71(1):52-62. PubMed ID: 21108561
    [Abstract] [Full Text] [Related]

  • 19. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function.
    Palazzuoli A, Deckers J, Calabrò A, Campagna MS, Nuti R, Pastorelli M, Pasqui AL, Bruni F, Auteri A, Puccetti L.
    Am J Cardiol; 2006 Nov 15; 98(10):1322-8. PubMed ID: 17134622
    [Abstract] [Full Text] [Related]

  • 20. Coronary collateral circulation in patients with chronic coronary total occlusion; its relationship with cardiac risk markers and SYNTAX score.
    Börekçi A, Gür M, Şeker T, Baykan AO, Özaltun B, Karakoyun S, Karakurt A, Türkoğlu C, Makça I, Çaylı M.
    Perfusion; 2015 Sep 15; 30(6):457-64. PubMed ID: 25358476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.